The DOI matches its Crossref record.
The role of interleukin-17 during acute rejection after lung transplantation
Open accessAbstract
Acute rejection (AR) is an important complication that can occur after lung transplantation and constitutes a risk factor for bronchiolitis obliterans syndrome, which is characterised by a neutrophilic airway inflammation. The specific aim of this study was to investigate the role of interleukin (IL)-17, which promotes chemotaxis of neutrophils by inducing IL-8 production, in AR. Cell differentials, mRNA and protein levels were quantified in bronchoalveolar lavages (BALs) taken from patients at 28 and 90 days after lung transplantation. The patient's rejection status was assessed by transbronchial biopsy. An AR was found in nine out of the 26 patients examined, 28 days after transplantation. The number of BAL neutrophils and lymphocytes were increased in these patients. IL-17 mRNA and protein levels in the BAL were increased in patients with AR. Analysis of BAL obtained at day 90 after transplantation, demonstrated that the increase in IL-17 had disappeared, whereas the increase in neutrophils and lymphocytes persisted. These data showed that interleukin-17 is temporarily upregulated in bronchoalveolar lavage during acute rejection. The number of lymphocytes and neutrophils are increased in bronchoalveolar lavage during acute rejection and may persist up to 2 months after acute rejection. These findings suggest that interleukin-17 is important in the pathophysiology of acute lung rejection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Afzali, B., Lombardi, G., Lechler, R. I., & Lord, G. M. (2007) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2007.03356.x · Cited by 762
Bullens, D. M., Truyen, E., Coteur, L., Dilissen, E., Hellings, P. W., Dupont, L. J., & Ceuppens, J. L. (2006) · Respiratory Research · doi:10.1186/1465-9921-7-135 · Cited by 587
Self-citationScriba, T. J., Kalsdorf, B., Abrahams, D.-A., Isaacs, F., Hofmeister, J., Black, G., Hassan, H. Y., Wilkinson, R. J., Walzl, G., Gelderbloem, S. J., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1962 · Cited by 410
Interleukin-17 and its expanding biological functions
Xu, S., & Cao, X. (2010) · Cellular & Molecular Immunology · doi:10.1038/cmi.2010.21 · Cited by 357
A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy
Yuan, X., Paez-Cortez, J., Schmitt-Knosalla, I., D'Addio, F., Mfarrej, B., Donnarumma, M., Habicht, A., Clarkson, M. R., Iacomini, J., Glimcher, L. H., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081937 · Cited by 302
Metadata
- Authors
- Vanaudenaerde, B. M., Dupont, L. J., Wuyts, W. A., Verbeken, E. K., Meyts, I., Bullens, D. M., Dilissen, E., Luyts, L., Van Raemdonck, D. E., & Verleden, G. M.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2006-04
- Volume
- 27
- Issue
- 4
- Pages
- 779-787
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2137325383
- Cited by
- 183
- References
- 0
- FWCI
- 15.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The role of interleukin-17 during acute rejection after lung transplantation. https://app.cochat.ai/papers/10.1183/09031936.06.00019405
- The paper
- Vanaudenaerde, B. M., Dupont, L. J., Wuyts, W. A., Verbeken, E. K., Meyts, I., Bullens, D. M., Dilissen, E., Luyts, L., Van Raemdonck, D. E., & Verleden, G. M. (2006). The role of interleukin-17 during acute rejection after lung transplantation. European Respiratory Journal. https://doi.org/10.1183/09031936.06.00019405
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.